Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Nulojix – Treatment for Preventing Acute Organ Rejection Post Kidney Transplantation

Drug Name (Brand / Generic)

Nulojix / Belatacept

Company / Licensee

Bristol Myers Squibb

Therapy Class

Immunosuppressant

Current Indication

Prevention of kidney transplant rejection

Market Sector

Renal physiology

Development Status

Approved in US and EU
Expand
Close
Close
Close
Globaldata

Identify the key trends in the immuno-oncology market over the next two years

Close

Go Top